''Tzaneio'' General Hospital of Piraeus
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chrysos, Georgios
REACT, NCT06294600: Clarithromycin Treatment to Prevent Sepsis Progression in CAP

Recruiting
3
330
Europe
Clarithromycin 500mg, A β-lactam/β-lactamase inhibitor or a 3rd generation cephalosporin or a fluoroquinolone, Tablets
Hellenic Institute for the Study of Sepsis
Community-acquired Pneumonia
11/25
01/26
MODIFY, NCT05909683: Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the Trial)

Recruiting
3
190
Europe
Change of antimicrobials based on BCID2 and Reveal Rapid AST tests. Stop of antimicrobials based on PCT results., Standard of Care
Hellenic Institute for the Study of Sepsis
Sepsis
07/25
07/25
NCT05279352: Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome

Recruiting
2a
30
Europe
FBR-002, Placebo
Fab'entech
COVID-19
06/22
07/22
BEYOND, NCT05304715 / 2021-005473-10: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Completed
2
44
Europe
Bezlotoxumab, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians., Normal saline 0.9% or 5% dextrose water, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians
Hellenic Institute for the Study of Sepsis
Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality
06/23
06/23

Download Options